DK0654267T3 - Carcinostatisk middel til hormonterapi indeholdende dienogest som aktiv komponent - Google Patents

Carcinostatisk middel til hormonterapi indeholdende dienogest som aktiv komponent

Info

Publication number
DK0654267T3
DK0654267T3 DK94118050T DK94118050T DK0654267T3 DK 0654267 T3 DK0654267 T3 DK 0654267T3 DK 94118050 T DK94118050 T DK 94118050T DK 94118050 T DK94118050 T DK 94118050T DK 0654267 T3 DK0654267 T3 DK 0654267T3
Authority
DK
Denmark
Prior art keywords
active component
hormone therapy
carcinostatic agent
therapy containing
containing dienogest
Prior art date
Application number
DK94118050T
Other languages
Danish (da)
English (en)
Inventor
Masaomi Obata
Masami Sato
Yukio Katsuki
Yasunori Shibutani
Original Assignee
Jenapharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jenapharm Gmbh filed Critical Jenapharm Gmbh
Application granted granted Critical
Publication of DK0654267T3 publication Critical patent/DK0654267T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK94118050T 1993-11-19 1994-11-15 Carcinostatisk middel til hormonterapi indeholdende dienogest som aktiv komponent DK0654267T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP29082393 1993-11-19

Publications (1)

Publication Number Publication Date
DK0654267T3 true DK0654267T3 (da) 2002-05-13

Family

ID=17760949

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94118050T DK0654267T3 (da) 1993-11-19 1994-11-15 Carcinostatisk middel til hormonterapi indeholdende dienogest som aktiv komponent

Country Status (9)

Country Link
US (1) US5652231A (fr)
EP (1) EP0654267B1 (fr)
AT (1) ATE215826T1 (fr)
AU (1) AU683098B2 (fr)
CA (1) CA2136140C (fr)
DE (1) DE69430356T2 (fr)
DK (1) DK0654267T3 (fr)
ES (1) ES2176218T3 (fr)
PT (1) PT654267E (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2306110A1 (fr) * 1997-10-17 1999-04-29 Mochida Pharmaceutical Co., Ltd. Agent therapeutique du leiomyome uterin, comprenant du dienogeste comme principe actif
CA2316320A1 (fr) * 1997-12-26 1999-07-08 Yoshihiro Futamura Inhibiteur de cytokine d'osteoresorption contenant du dienogest en tant que principe actif
JP4418105B2 (ja) 1997-12-26 2010-02-17 持田製薬株式会社 ジエノゲストを有効成分とする血管新生抑制剤
DE19825591A1 (de) * 1998-06-09 1999-12-23 Jenapharm Gmbh Pharmazeutische Kombinationen zum Ausgleich eines Testosteron-Defizits beim Mann mit gleichzeitigem Schutz der Prostata
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
DE19908762A1 (de) * 1999-02-18 2000-08-31 Jenapharm Gmbh Verwendung von Dienogest in hoher Dosierung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2718872A1 (de) * 1976-06-14 1977-12-22 Jenapharm Veb Verfahren zur herstellung von neuen gona-4,9(10)-dienen
JPS6372627A (ja) * 1986-09-17 1988-04-02 Mitsubishi Kasei Corp 子宮内膜症治療薬
JPS643122A (en) * 1987-06-25 1989-01-06 Mitsubishi Kasei Corp Remedy for endometriosis
JPS643121A (en) * 1987-06-25 1989-01-06 Mitsubishi Kasei Corp Remedy for endometriosis
DE69032648T2 (de) * 1989-07-07 1999-04-08 Endorecherche Inc Androgenderivate zur Hemming der Aktivität der Sexualsteroide

Also Published As

Publication number Publication date
EP0654267B1 (fr) 2002-04-10
DE69430356D1 (de) 2002-05-16
CA2136140A1 (fr) 1995-05-20
AU683098B2 (en) 1997-10-30
AU7888394A (en) 1995-05-25
DE69430356T2 (de) 2002-08-14
ATE215826T1 (de) 2002-04-15
EP0654267A1 (fr) 1995-05-24
PT654267E (pt) 2002-09-30
CA2136140C (fr) 2007-10-30
US5652231A (en) 1997-07-29
ES2176218T3 (es) 2002-12-01

Similar Documents

Publication Publication Date Title
EP1033981A4 (fr) Formulations et procedes de reduction de la toxicite d'agents antineoplasiques
DE69527509T2 (de) Hydrogelformulierung mit gesteuerter freisetzung
EP0943328A3 (fr) Thérapie combinée dans la prophylaxe et/ou dans le traitement de l'hyperplasie benigne de la prostate
TW234691B (fr)
MY118151A (en) Pharmaceutical formulations containing voriconazole.
ES2153862T3 (es) Bisulfan de administracion parenteral para el tratamiento de enfermedades malignas.
FI951856A (fi) Farmaseuttinen koostumus osteoporoosin hoitamiseksi
CA2157142A1 (fr) Traitement des maladies causees par les desordres de la glande sebacee
EP0754457A4 (fr) Agent anti-obesite
KR960702320A (ko) 감마 인터페론의 안정한 액체 조성물 (Stable Liquid Compositions of Gamma Interferon)
EP0620004A4 (fr) Compositions medicinales.
GR3015014T3 (en) Compositions for topical administration containing fluticasone propionate and oxiconazole or its salts.
DK0654267T3 (da) Carcinostatisk middel til hormonterapi indeholdende dienogest som aktiv komponent
MX9504023A (es) Composicion farmaceutica y transdermicamente activa que contiene acido 5-aminolaevulinico y procedimiento para su preparacion.
ZA963743B (en) Transdermal therapeutic system (TTS) for the administration of testosterone
IL105475A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING 1a, 24(R) - DIHYDROXY-22(E)-DEHYDRO- VITAMIN D3 FOR TREATING OSTEOPOROSIS
ITRM910730A1 (it) Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali.
EP0151987A3 (en) Means for the treatment of diseases of the veins and the anal region
ES2194129T3 (es) Compuestos farmaceuticos.
LT96094A (en) The active ingredient of pharmaceutical composition for treating constipation
ATE169819T1 (de) (-)-metrifonat enthaltendes arzneimittel
AU691674B2 (en) Preventive and remedy for diarrhea
KR930702016A (ko) 골다공증 치료제
KR930019216A (ko) 종양 치료제
DK0608648T3 (da) Højdoserede vitamin A-præparater